GlassScriptPhysician profile
Michael J Cannon
NPI 1033131495
$17,823.57
in general payments reported to CMS, 2019-2025
13 companies · $55.27 in 2025
The $55.27 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $48.96 · 2021: $60.38 · 2022: $14K · 2023: $3,094 · 2024: $66.65 · 2025: $55.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $215.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $17,347.20 | 2022-2023 | Davinci Xi, Da Vinci Surgical System |
| Organon LLC | $77.71 | 2022-2024 | Nexplanon |
| Boston Scientific Corporation | $74.83 | 2019-2021 | |
| Abbvie INC. | $62.56 | 2021-2022 | |
| Conmed Corporation | $57.44 | 2024-2025 | Airseal, Conmed Specimen Retrieval, Vcare |
| Ethicon US, LLC | $51.65 | 2019-2024 | Ethicon, Stratafix, Enseal |
| Therapeuticsmd, INC. | $30.69 | 2019 | |
| Roche Diagnostics Corporation | $29.78 | 2019 | |
| Astellas Pharma US INC | $29.60 | 2019 | |
| Kci USA, INC. | $21.41 | 2020 | |
| Exeltis, USA INC. | $15.73 | 2025 | Slynd |
| Hologic Sales and Service, LLC | $13.95 | 2023 | Acessa Provu System |
| Allergan, INC. | $11.02 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cannon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.